68-5

89/120

) Watada H: Evidence-based comparison of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors. J Diabetes Investig, 2020; 11: 17-19, 10.1111/jdi.13131.) Watada H: Clinical evidence regarding factors linking metabolic abnormal obesity to pancre‑atic β-cell dysfunction. J Diabetes Investig, 2020; 11: 798-800.) Watada H: Current understanding of the effect of sodium-glucose co-transporter-2 inhibitors in Asian patients with diabetes mellitus. Diabetol Int, 2020; 11: 242-244, 10. 1007/s13340-020-00443-9.) Nakajima K*, Miranda A*, Craig DW, Shek‑htman T, Kmoch S, Bleyer A, Szelinger S, Kato T#, Kelsoe JR#: Ntrk1 mutation co-seg‑regating with bipolar disorder and medullary cystic kidney isease in a multiplex family causes depression-like behavior in mice. Translational Psychiatry, 2020; 10: 407. (*co- first authors, #co-corresponding authors)) Bagge EK, Fujimori-Tonou N, Kubota- Sakashita M, Kasahara T, Kato T*: Unbiased PCR-free spatio-temporal mapping of the mtDNA mutation spectrum reveals brain treated in a Japanese center. Journal of Diabetes Investigation, 2020; 11: 1564-1569, 10.1111/jdi.13288. 42) Yamasaki N, Tamura Y, Kaga H, Sato M, Kiya M, Kadowaki S, Suzuki R, Furukawa Y, Sugimoto D, Funayama T, Someya Y, Kakehi S, Nojiri S, Satoh H, Kawamori R, Watada H: A decrease in plasma glucose levels is required for increased endogenous glucose production with a single administration of a sodium-glu‑cose co-transporter-2 inhibitor tofogliflozin. Diabetes Obes Metab, 2020. 10.1111/dom.14312.＊ 43) Katahira T, Miyatsuka T, Miura M, Suzuki L, Himuro M, Nishida Y, Satoh H, Watada H: Conversion of pancreatic α cells into insu‑lin-producing cells modulated by β-cell insufficiency and supplemental insulin admin‑istration. Biochem Biophys Res Commun, 2020; 521: 178-183.〈Reviews〉 1 2 3Psychiatry and Behavioral Science〈Original Articles〉 1 2region-specific responses to replication insta‑bility. BMC Biology, 2020; 18: 150.) Sawada T, Chater TE, Sasagawa Y, Yoshimura M, Fujimori-Tonou N, Tanaka K, Benjamin KJM, Paquola ACM, Erwin JA, Goda Y, Nikaido I, Kato T*: Developmental excitation- inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoids. Molecular Psychiatry, 2020; 25, 2695-2711.) Kato T, Ishigooka J, Miyajima M, Watabe K, Fujimori T, Masuda T, Higuchi T, Vieta E: Double-blind, placebo-controlled study of lurasidone monotherapy for the treatment of bipolar I depression. Psychiatry and Clinical Neurosciences, 2020; 74: 635-644.) Ikegame T, Bundo M, Okada N, Murata Y, Koike S, Sugawara H, Saito T, Ikeda M, Owada K, Fukunaga M, Yamashita F, Koshi‑yama D, Natsubori T, Iwashiro N, Asai T, Yoshikawa A, Nishimura F, Kawamura Y, Ishigooka J, Kakiuchi C, Sasaki T, Abe O, Hashimoto R, Iwata N, Yamasue H, Kato T, Kasai K, Iwamoto K: Promoter Activity- Based Case-Control Association Study on SLC6A4 Highlighting Hypermethylation and Altered Amygdala Volume in Male Patients with Schizophrenia. Schizophrenia Bulletin, 2020; 46: 1577-1586.) Nakamura T, Harada K, Kamiya T, Takizawa M, Küppers J, Nakajima K, Gütschow M, Kitaguchi T, Ohta K, Kato T, Tsuboi T: Gluta‑mine-induced signaling pathways via amino acid receptors in enteroendocrine L cell line. Journal of Molecular Endocrinology, 2020; 64: 133-143.) Kasahara T*, Sakashita-Kubota M, Nagat‑suka Y, Hirabayashi Y, Itohara S, Hanasaka T, Tohyama K, Kato T*: Cardiolipin is essen‑tial for early embryonic viability and mito‑chondrial integrity of neurons in mammals. FASEB J, 2020; 34: 1465-1480.) Amare AT, et al: Association of polygenic score for major depression with response to lithium in patients with bipolar disorder. Molecular Psychiatry, 2020.) Tokumitsu K, et al: Prevalence of perinatal depression among Japanese women: a meta- analysis. Ann Gen Psychiatry, 2020; 19: 41. doi: 3 4 5 6 7 8 9539